A detailed history of Gamma Investing LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Gamma Investing LLC holds 216 shares of ADPT stock, worth $1,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
216
Previous 407 46.93%
Holding current value
$1,080
Previous $1.31 Million 40.12%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

SELL
$2.34 - $3.96 $446 - $756
-191 Reduced 46.93%
216 $782,000
Q4 2023

Feb 01, 2024

BUY
$3.46 - $5.33 $1,408 - $2,169
407 New
407 $1.49 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $714M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.